Can Alzheimer’s treatment now be taken at home?
Quick answer: A weekly subcutaneous form of lecanemab can reduce infusion-center visits for eligible people with early Alzheimer’s, but monitoring still matters.
A weekly subcutaneous form of lecanemab can reduce infusion-center visits for eligible people with early Alzheimer’s, but monitoring still matters.
- Confirm that the diagnosis is mild cognitive impairment or mild dementia due to Alzheimer’s.
- Ask a specialist about eligibility, expected benefit, and the risk of amyloid-related imaging abnormalities.
- Follow the prescribed MRI monitoring schedule even when injections happen at home.
- Use the autoinjector only after training and keep a written schedule for the two 250 mg injections that make up the weekly 500 mg dose.
Good to know: LEQEMBI can slow progression for some eligible patients; it is not a cure and does not restore lost memory.
Source: Eisai / Biogen announcement
Ask AI about this tip
Send this tip to your favorite AI assistant for a plain-language walkthrough, follow-up questions, or help applying it to your device.
Was this helpful?